Treatment-resistant Depression
Showing 1 - 25 of 27
Treatment-Resistant Depression Trial (Active rTMS with short inter-session interval, Sham rTMS with short inter-session
Not yet recruiting
- Treatment-Resistant Depression
- Active rTMS with short inter-session interval
- +2 more
- (no location specified)
Apr 24, 2023
Treatment-resistant Depression Trial in Galway (GH001, Placebo)
Recruiting
- Treatment-resistant Depression
- GH001
- Placebo
-
Galway, IrelandInvestigational Site
Apr 5, 2023
Treatment-Resistant Depression Trial in Hangzhou (non-invasive transcranial deep brain stimulation, Sham stimulation, Motor
Recruiting
- Treatment-Resistant Depression
- non-invasive transcranial deep brain stimulation
- +3 more
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Zhejiang University
Mar 8, 2023
Treatment-resistant Depression Trial in Toronto (Psilocybin 25 mg, Risperidone 1 MG, Placebo)
Not yet recruiting
- Treatment-resistant Depression
- Psilocybin 25 mg
- +2 more
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Feb 2, 2023
MDD, Treatment-Resistant Depression, Depression Trial run by the NIMH (Placebo, TS-161 (50 - 100 mg))
Recruiting
- Major Depressive Disorder
- +2 more
- Placebo
- TS-161 (50 - 100 mg)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Treatment-resistant Depression Trial in Hangzhou (active iTBS, sham rTMS)
Recruiting
- Treatment-resistant Depression
- active iTBS
- sham rTMS
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Zhejiang University
Jan 12, 2023
Treatment-resistant Depression Trial (Non-invasive brain stimulation protocol (intermittent theta burst protocol (iTBS))
Not yet recruiting
- Treatment-resistant Depression
- Non-invasive brain stimulation protocol (intermittent theta burst protocol (iTBS)) combined with pleasant odors delivered during the iTBS procol.
- Non-invasive brain stimulation protocol (intermittent theta burst protocol (iTBS)) delivered alone.
- (no location specified)
Dec 13, 2022
Treatment-resistant Depression Trial in Freiburg, Bonn (Vercise GEVIA deep brain stimulation (DBS) system)
Recruiting
- Treatment-resistant Depression
- Vercise GEVIA deep brain stimulation (DBS) system
-
Grenoble, France
- +1 more
Nov 2, 2022
Treatment-resistant Depression Trial in France (Systematic maintenance rTMS, rTMS course in case of relapse, sham rTMS)
Active, not recruiting
- Treatment-resistant Depression
- Systematic maintenance rTMS
- +2 more
-
Angers, France
- +18 more
Sep 15, 2022
Suicidal Ideation, Treatment-resistant Depression Trial in San Diego (Accelerated Theta Burst Stimulation)
Recruiting
- Suicidal Ideation
- Treatment-resistant Depression
- Accelerated Theta Burst Stimulation
-
San Diego, CaliforniaUCSD Interventional Psychiatry
Sep 9, 2022
Treatment-resistant Depression, MDD Trial in Taipei (Prolonged intermittent theta burst stimulation (piTBS), 20Hz rTMS, sham
Recruiting
- Treatment-resistant Depression
- Major Depressive Disorder
- Prolonged intermittent theta burst stimulation (piTBS)
- +2 more
-
Taipei, TaiwanTaipei Veterans General Hospital, Taiwan
Aug 15, 2022
Treatment-Resistant Depression Trial (MIJ821 Subcutaneous Injection - low dose, MIJ821 Subcutaneous Injection - medium dose,
Not yet recruiting
- Treatment-Resistant Depression
- MIJ821 Subcutaneous Injection - low dose
- +3 more
- (no location specified)
Jul 8, 2022
Ketamine on Neurological Activity as Measured by
Recruiting
- Treatment-resistant Depression
- Observational - no intervention
-
Austin, TexasHeading Health
Jun 17, 2022
Late-life Depression, Treatment-resistant Depression Trial in London (Sahaj Samadhi Meditation (SSM), Health Enhancement Program
Terminated
- Late-life Depression
- Treatment-resistant Depression
- Sahaj Samadhi Meditation (SSM)
- Health Enhancement Program (HEP)
-
London, Ontario, CanadaLondon Health Sciences Centre
Apr 12, 2022
Treatment-resistant Depression, MDD Trial in Taipei city (Midazolam (active ), Ketamine and Midazolam (active ), Ketamine)
Recruiting
- Treatment-resistant Depression
- Major Depressive Disorder
- Midazolam (active placebo)
- +2 more
-
Taipei city, TaiwanTaipei Veterans General Hospital, Taiwan
Apr 1, 2022
Persistent Depressive Disorder, Treatment-resistant Depression Trial in Germany (inpatient CBASP individual therapy, inpatient
Not yet recruiting
- Persistent Depressive Disorder
- Treatment-resistant Depression
- inpatient CBASP individual therapy
- +10 more
-
Berlin, Germany
- +5 more
Aug 25, 2021
Treatment-resistant Depression Trial in Berlin, Mannheim (Psilocybin, Nicotinamide)
Recruiting
- Treatment-resistant Depression
-
Berlin, Germany
- +1 more
Jul 28, 2021
Treatment-resistant Depression Trial in Taipei (Nurse-led cognitive-behavioral-based group intervention)
Completed
- Treatment-resistant Depression
- Nurse-led cognitive-behavioral-based group intervention
-
Taipei, TaiwanChia-Yi Wu
May 6, 2021
Treatment-resistant Depression Trial in Worldwide (Esketamine, Placebo, Duloxetine (Oral Antidepressant))
Completed
- Treatment-resistant Depression
- Esketamine
- +5 more
-
Birmingham, Alabama
- +49 more
May 18, 2020
Treatment-resistant Depression Trial in Worldwide (Esketamine (Intranasal Spray), Duloxetine (Oral Antidepressant), Escitalopram
Completed
- Treatment-resistant Depression
- Esketamine (Intranasal Spray)
- +4 more
-
New Haven, Connecticut
- +109 more
Apr 27, 2020
Treatment-resistant Depression Trial in Worldwide (Esketamine, Placebo, Duloxetine (Oral Antidepressant))
Completed
- Treatment-resistant Depression
- Esketamine
- +5 more
-
Birmingham, Alabama
- +90 more
Apr 17, 2020
Treatment-Resistant Depression Trial (Deep Brain Stimulation)
Unknown status
- Treatment-Resistant Depression
- Deep Brain Stimulation
- (no location specified)
Oct 13, 2016
Treatment-Resistant Depression Trial in Beirut (Focal Electrically Administered Seizure Therapy)
Unknown status
- Treatment-Resistant Depression
- Focal Electrically Administered Seizure Therapy
-
Beirut, LebanonAmerican University of Beirut Medical Center
Apr 5, 2016